While acute pain serves as a protective mechanism designed to warn an individual of potential or actual damaging stimuli, chronic pain provides no benefit and is now considered a disease in its own right. Since the advent of human brain imaging techniques, many investigations that have explored the central representation of acute and chronic pain have focused on changes in higher order brain regions. In contrast, far fewer have explored brainstem and spinal cord function, mainly due to significant technical difficulties. In this review, we present some of the recent human brain imaging studies that have specifically explored brainstem and spinal cord function during acute noxious stimuli and in individuals with chronic pain. We focus particularly on investigations that explore changes in areas that receive nociceptor afferents and compare humans and experimental animal data in an attempt to describe both microscopic and macroscopic changes associated with acute and chronic pain.
Introduction
The advent of human brain imaging technologies during the 1970s, such as computed axial tomography, positron emission tomography, and magnetic resonance imaging, triggered a dramatic increase in progress in the exploration of human brain anatomy and function. Prior to the development of such technologies, human brain exploration, particularly in healthy individuals, was limited and relied primarily on technologies such as two-dimensional X-rays and electroencephalograms. The real catalysts driving an exponential growth in human brain exploration were the development of magnetic resonance imaging (MRI) in the late 1970s and functional magnetic resonance imaging (fMRI) in the early 1990s; these techniques also revolutionized the diagnosis and treatment of most brain diseases. The continued development of MRI scanning and analysis techniques, particularly over the past decade, has allowed far more rigorous scientific exploration of the human brain. For example, it is now possible to noninvasively explore subtle changes in regional brain anatomy, evoked and resting changes in neural activity, regional biochemistry, and even functional and anatomical connectivity between various brain regions in living humans.
The vast majority of investigations in human brain imaging explore changes in the structure and function of higher brain regions, particularly in the cerebral cortex, with relatively few investigations focused on brainstem and spinal cord. This bias stems not only from the fact that many relatively common and debilitating neurological conditions such as schizophrenia, dementia, and depression are mediated by changes in higher order functioning, but more importantly from the fact that investigating the brainstem and spinal cord is extremely difficult in living humans due to their relatively small size. A number of factors compound these difficulties, for example, the intricate functional mosaic of the brainstem necessitates the collection of small voxels with low signal-tonoise ratios, susceptibility due to fluid tissue interfaces in areas such as the pontine cistern, and movement-related artifacts due to respiratory and cerebrospinal fluid pulsations. These limitations pose even greater challenges when exploring the spinal cord and as a consequence only a few studies have used brain imaging to explore below the level of the spinomedullary junction. Nonetheless, gradual improvements in scanner hardware, particularly increased MRI field strengths, have led to increases in signal-to-noise ratios and specialized imaging paradigms now allow for reduced signal dropout in susceptible 703911N ROXXX10.1177/1073858417703911The NeuroscientistHenderson and Keay
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1 Department of Anatomy and Histology, University of Sydney, Sydney, New South Wales, Australia brainstem regions. More importantly improved image analysis techniques, particularly software that allows improved spatial normalization of brainstem structures, have resulted in greatly improved accuracy and feasibility of brainstem imaging. Unfortunately, the relatively low spatial resolution of positron emission tomography means that investigating brainstem function using this form of imaging remains unfeasible.
In this review, we present some of the recent human brain imaging studies that have specifically explored brainstem and spinal cord function during acute noxious stimuli, as well as function and structure in individuals with chronic pain. We focus particularly on those studies that have restricted their investigations to the brainstem and spinal cord with specific attention to the regions that receive nociceptor afferents, that is, the dorsal horn and spinal trigeminal nucleus (SpV). Furthermore, we aim to compare results obtained in humans with those obtained in experimental animals in an attempt to describe both microscopic and macroscopic changes associated with acute and chronic pain.
Brainstem and Spinal Cord Function during Acute Pain
Acute pain serves as a protective mechanism designed to warn an individual of potential or actual damaging stimuli and, when possible, to remove that individual from the stimulus. Although the perception of pain and in particular its associated unpleasantness are important for learning and thus subsequent avoidance of similar stimuli, it is the overt behavioral response removing an individual from a damaging stimulus that is most often critical for survival. The brain drives action and the survival of an organism depends critically on the appropriateness of actions taken. It has been argued that the perceptual and cognitive elements of acute pain arose as an error-correction mechanism to optimize the ongoing action response selection of the organism. Given that the primary purpose of acute pain is one of a behavioral drive to survive, one would expect that the neural circuitry responsible for this drive be represented in phylogenetically older parts of the brain. As such, to understand fully the central representation of pain, one must explore areas such as the brainstem and spinal cord.
Primary Afferent Synapse
Over the past half a century, numerous investigations in experimental animals have revealed that peripheral nerves carrying noxious inputs from the body and orofacial regions synapse in the spinal cord and brainstem, respectively. Using a variety of techniques that cannot be applied readily in humans, including single cell electrophysiology, detection of the expression of immediate early gene, c-fos, a marker of neural activation, immunohistochemical, and tract tracing techniques, numerous studies have established that noxious inputs primarily activate neurons within the dorsal horn of the spinal cord and in the SpV (Todd 2010) . More specifically, noxious inputs that are transmitted quickly and feel sharp, hot and are accurately localized, tend to terminate most superficially in spinal cord lamina I and II, whereas noxious inputs that are transmitted relatively slowly and are often perceived as dull and difficult to localize tend to terminate in deeper lamina such as lamina V. A similar superficial versus deep organization exists in the portion of the SpV found in the caudal medulla for noxious inputs that originate in the orofacial region (Sessle 2000) . From these neurons in the dorsal horn and SpV, fibers project rostrally to carry these noxious inputs to various regions of the brainstem and diencephalon and also up to a range of cortical regions via thalamic relay nuclei.
While the functional organization of noxious inputs to the spinal cord and SpV in experimental animals is understood with a great degree of detail, it is extremely difficult to determine if similar patterns of termination of peripheral nerves carrying noxious inputs occurs in humans. Over the past decade a number of investigators have begun to use brain-imaging techniques to explore spinal cord activation patterns during noxious stimuli. Almost all of these investigations use repeated noxious thermal stimuli to evoke pain since thermal stimuli can be repeated multiple times during a single scan, which lends itself to increased statistical power and reduces some of the technical problems associated with movement and cerebrospinal fluid-related artifacts. Additionally, these investigations almost always stimulate the hand and record blood oxygen level dependent signal in the cervical spinal cord. This approach has the advantage of providing a larger cross-sectional area compared to thoracic and lumbar spinal cord regions and is associated with less respiratory related movement. These studies, though mostly qualitative in nature, report signal change patterns that are broadly consistent with findings in experimental animals. That is, they report signal intensity increases within the spinal cord at the appropriate rostrocaudal level for the dermatome being stimulated, on the side ipsilateral to the stimulus, and some report signal increases preferentially within the region of the dorsal horn (Brooks and Tracey 2005; Cahill and Stroman 2011; Ghazni and others 2010; Rempe and others 2015; Summers and others 2010) . One recent investigation by Nash and colleagues compared spinal cord activation during repeated thermal noxious stimuli applied to the shoulder and hand. Consistent with results in experimental animals, they found that during nociceptive stimulation of the left or right shoulder and left or right hand, signal intensity increased in the dorsal horn of the cervical spinal cord ipsilateral to the stimulus (Nash and others 2013) (Fig. 1 ). Although this and other studies exploring spinal cord activation during acute noxious stimuli are informative, they lack adequate spatial resolution to accurately explore activation patterns in the superficial versus deep dorsal horn, although such differentiation may now be possible with the introduction of higher field strength MRI scanners.
Using the orofacial region to explore activity changes at the primary afferent synapse in the SpV during acute noxious stimuli has a number of distinct advantages over exploration of the spinal dorsal horn. First, the brainstem is significantly larger than the spinal cord and shows considerably less movement-related artifacts. Second, noxious inputs from the orofacial region synapse in the SpV, which is relatively large, traversing the caudal pons, medulla, and into the upper cervical spinal cord (Sessle, 2000) . Third, the clear spatial separation of the principle (or chief) sensory nucleus of the trigeminal in the dorsolateral rostral pons, which processes orofacial discriminatory touch, from the SpV which processes noxious inputs, allows for the investigation of nociceptive versus nonnociceptive processing within the human brainstem simultaneously using high resolution fMRI.
Capitalizing on these advantages, a number of investigations have begun to explore activation patterns in SpV during acute orofacial pain in humans. As with the spinal cord, repeated noxious heat stimuli are most commonly used to explore SpV function. It is known from both experimental animal and human lesion investigations that noxious afferents originating in skin of the face terminate selectively in the caudalis division of SpV (SpVc). This subnucleus is organized in a somatotopic manner with inputs from each of the three trigeminal nerve divisionsophthalmic, maxillary, and mandibular-terminating along the entire length of the nucleus. This termination pattern is associated with concentric dermatomes originating at the tip of the nose and radiating toward the crown of the head, with the ear and chin represented at progressively more caudal levels of the SpVc (Sessle 2006) (Fig. 2 ). This unusual pattern of terminations of noxious input is responsible for the characteristic "onion skin" pattern of loss of pain and temperature perception that occurs in humans following lesions at discrete rostrocaudal levels of SpVc (Dejerine 1914) . This distinctive pattern of SpVc organization has been revealed in a number of brain imaging investigations. For example, DaSilva and others (2002) used repeated noxious thermal stimuli applied to different regions of the face and reported a pattern of rostrocaudal activation within SpVc, with stimuli closer to the nose activating the rostral SpVc and stimuli further away from the nose activating more caudal SpVc regions (Fig. 2) .
Remarkably, in addition to the SpV, the same group of investigators also reported somatotopic signal intensity changes during facial stimulation in the trigeminal ganglion (Borsook and others 2003) . They found that innocuous brushing and noxious thermal stimulation in the regions supplied by the ophthalmic, maxillary, and mandibular divisions of the trigeminal nerve evoked differential activation patterns within the trigeminal ganglion, consistent with the known location of afferent fibers derived from anatomical investigations. This is remarkable given the small size of the trigeminal ganglion and further calls into question what exactly fMRI signal intensity is a measuring. There is a prevailing thought the blood oxygen level dependent fMRI, the most common form of fMRI, is a measure primarily of synaptic transmission (Logothetis and others 2001), though the abovementioned results suggest otherwise.
In addition to noxious heat applied to the skin, some investigators have also explored brainstem activation patterns during pain of deeper origin. Since very little of the pain that presents major clinical challenges arises from cutaneous structures but rather arises from muscle, viscera, or from damaged nerves, it is important that we begin to understand differences in the processing of acute pain originating from other tissues, even if the methodology does not lend itself to repeated stimuli and its associated increased statistical power. Nash and colleagues (2009) compared the SpV activation patterns during acute facial muscle and cutaneous pain evoked by hypertonic saline injections into the masseter muscle and the overlying skin, respectively. Although both types of acute pain evoked significant increases in signal intensity within the ipsilateral SpVc, the pattern of activation in more rostral regions of SpV differed depending on whether the noxious stimulus was delivered to skin or muscle. Data from experimental studies in animals has shown that the SpV can be divided into three major divisions: oralis, interpolaris, and caudalis, from rostral to caudal (Sessle 2000) . Although the roles of these subnuclei have begun to be explored in experimental animals, their roles in processing different forms of noxious inputs in humans remains relatively unexplored. Nash and colleagues found that both cutaneous and muscle pain each activate the oralis division of SpV; however, only cutaneous pain activated the interpolaris division (Fig. 3) . It is possible that these differential patterns of activation reflect differences in Figure 2 . Imaging of the human brainstem during acute thermal noxious stimuli applied to the skin of the face. It can be seen that activity increases in the ipsilateral (to noxious stimulus) side of the spinal trigeminal nucleus (SpV). Furthermore, stimuli closer to the nose activate at the rostral region whereas stimuli further from the nose activate the caudal SpV. Modified from others 2002 (2002) . afferent pathways that drive the different perceptual, emotional, and motoric consequences of deep compared with superficial pain ( Lewis 1942 ).
Higher Brainstem Regions
Apart from simple reflexive withdrawal responses to acute noxious stimuli, which are organized at the level of the spinal cord and SpV, more complex and arguably more critical behavioral responses to acute pain are integrated in higher brainstem regions. Second-order neurons that originate in the dorsal horn/SpV terminate in various regions of the brainstem including the reticular formation, which can alter an individual's overall level of arousal. Behaviorally more important is the projection of dorsal horn/SpV neurons to the midbrain periaqueductal gray matter (PAG) via the spino-and trigemino-mesencephalic pathways ( Blomqvist and Craig 1991 ; Keay and others 1997 ) . The day-to-day behavioral responses to pain include the well-described defensive behaviors of fight and flight, which are highly integrated responses aimed at dealing with the noxious stimulus and removing the entire organism from potential danger. These behavioral responses are mediated by the midbrain PAG, at least in experimental animals ( Keay and Bandler 2008 ) , and given their fundamental nature, it is assumed that the circuitry responsible for them is preserved in humans, although this is yet to be definitively established.
A large number of studies have shown that fight-flight, defensive behaviors can be evoked by direct stimulation of neurons in the dorsal PAG region of the midbrain in a range of species ( Bandler and Keay 1996 ) . Although the expression of these behaviors can be modulated by higher brain regions, it is the PAG that contains the neural hardware required to produce integrated defensive behaviors ( Keay and Bandler 2008 ) . That is, in addition to the motor response characterizing fight or flight, PAG stimulation also increases arterial pressure and heart rate, adjusts blood flows to support the fight or flight behaviors, and enhances vigilance and reactivity, all of which are coupled to a powerful non -opioid-dependent analgesia. These behaviors are regulated by somatotopically organized columns of neurons that run the length of the PAG, which can be activated either by direct spinal and SpV inputs, or by descending projections from hypothalamic and cortical regions. These active emotional coping behaviors facilitate the successful escape from, or avoidance of further noxious stimulation ( Fig. 4 ) .
The detailed understanding of the organization of the dorsal PAG and its role in defensive behaviors in experimental animals is not yet complemented by data from humans. A major limitation in investigating central circuits that mediate the active emotional coping responses of fight or flight in people is the fact that the scanner environment requires an individual to remain still and as a consequence these "natural" behavioral responses to acute pain need to be inhibited. Indeed, this makes any interpretation of PAG activation during acute noxious stimuli difficult given that through this contextual inhibition the previously "escapable" stimulus has now assumed an "inescapable" quality as subjects cannot remove themselves from the noxious source (though one could argue that it is in a sense escapable since the duration of the stimuli are almost always brief and furthermore one can ask to be removed at any point). Nevertheless, in a recent review, 25 human brain imaging studies identified PAG activation during acute noxious stimuli, although these studies did not focus specifically on the brainstem. Furthermore, they did not use brainstem-specific analysis protocols and the accuracy of PAG localization in many of these investigations is quite variable (Linnman and others 2012) . The vast majority of these studies used "escapable" cutaneous noxious stimuli rendered "inescapable," which combined with the constraints of the spatial resolution of imaging the PAG, make an accurate functional mapping of acute pain representations in the PAG very difficult.
As described above, the dorsal PAG is also the central origin of a relatively short duration, non-opioid-mediated descending modulation of incoming noxious inputs. That is, PAG stimulation can produce a powerful analgesia, inhibiting incoming noxious information at the dorsal horn/SpV via its projections to the rostral ventral medulla (Fields and others 1991) . This powerful but brief analgesia is suggested to allow the uninterrupted execution of the avoidance behaviors triggered by an acute noxious stimulus. Although this analgesic circuitry has been investigated extensively in experimental animals, it remains relatively unexplored in humans. In addition to the difficulty in exploring the brainstem in humans, it is difficult to induce analgesic responses in humans. Although recently, in an extremely technically challenging experiment in which both the brain and the cervical spinal cord were imaged simultaneously, it was found that during noxious stimuli, the strength of resting signal co-variation between the PAG and the dorsal horn region activated during the noxious stimuli could accurately predict individual subject's pain intensity ratings (Sprenger and others 2015) . The authors suggest that this coupling is consistent with the notion that descending PAG influences are providing a continuous balance between noxious input facilitation and inhibition. This balance is also consistent with experimental animal investigations that have revealed the presence of "on" and "off" cells in the rostral ventromedial medulla (Fields and others 1991) . On stimulation, these neurons can inhibit or excite neurons in the dorsal horn/SpV and be pro-or anti-nociceptive in nature. Although not exploring pain or analgesia, a recent study used a 7 Tesla MRI, collecting 0.75 mm isotropic voxels to examine PAG activation during the viewing of emotionally aversive images (Satpute and others 2013) . The authors report activation in discrete columns along the rostrocaudal length of the PAG consistent with the structural and functional neurobiological observations in experimental animal investigations. This study shows the potential for exploring the function of very small regions of the brainstem including individual PAG columns using newly developed high-field MRI scanners.
Of course the PAG is not the only brainstem site capable of altering incoming noxious inputs. Experimental animal studies have shown that a specific region of the dorsal medulla, the subnucleus reticularis dorsalis (SRD), is critical for the expression of conditioned pain modulation (Bouhassira and others 1992; Le Bars and others 1979). Conditioned pain modulation occurs when the intensity of a painful stimulus is reduced by the application of a second painful stimulus at a distant site. It is only recently that the SRD has been confirmed to play a role in this analgesic mechanism in humans. Using fMRI, Youssef and others (2016) found that whether an individual perceived a reduction in pain intensity during orofacial noxious stimulation due to the application of a second distant noxious stimulus was associated with reduced signal intensity changes in three brainstem regions: SpV, SRD, and in the region of the parabrachial nucleus (Fig. 5) .
Given evidence that an individual's CPM ability is associated with increased postoperative pain (Yarnitsky 2010) , the presence of persistent pain conditions (Julien and others 2005; King and others 2009) , and the effectiveness of analgesic medications (Yarnitsky and others 2012) , investigations in healthy controls in which brainstem endogenous analgesic circuits are defined are important as they provide the basis for investigating these circuits in individuals with more clinically relevant persistent pain. Between test stimuli 4 and 5, a bolus of hypertonic saline was injected into the tibialis anterior muscle, producing sustained muscle pain (conditioning stimulus). This period of test and conditioning stimuli is the CPM period (grey shading). In 23 of the 54 subjects, the conditioning stimulus resulted in a significant reduction in pain intensity of the test stimuli (CPM subjects; grey shading), whereas in 31 subjects, there was no change in pain rating of the test stimuli (noCPM; black shading) (*P < 0.05). (B) Brainstem regions in which CPM analgesia was associated with a significant reduction in signal intensity increases during test stimuli. The presence of a CPM response was associated with signal intensity changes reductions during test stimuli in the presence of a conditioning stimulus in the region of the spinal trigeminal nucleus (SpV), subnucleus reticularis dorsalis (SRD), and parabrachial (PB) nucleus. The location of each slice in Montreal Neurological Institute space in indicated at the top right of each axial slice. ipsi = ipsilateral to the test stimuli. Modified from Youssef and others (2016) .
Brainstem and Spinal Cord Function and Chronic Pain
Acute pain by definition resolves relatively quickly and is not usually associated with a significant clinical impact. In contrast, chronic pain, that is, pain that persists for at least 3 months and often years, has a significant clinical impact and poses an incredible burden on the individual. While exploring the pattern of brainstem activation during acute noxious stimuli is interesting, there is mounting evidence that chronic pain is not simply the prolonged activation of "acute" pain pathways. Instead, much evidence shows that chronic pain is associated with a complex series of changes throughout the neuroaxis including changes in receptor expression and function, neural anatomy, and biochemistry and changes in non-neural cells such as astrocytes and microglia, both at the primary afferent synapse and higher brainstem regions. Furthermore, these changes interact with changes in analgesic brainstem circuits, which makes unravelling the underlying changes responsible for the generation and maintenance of chronic pain extremely challenging.
One type of chronic pain that is relatively common and is extremely difficult to treat is that arising from nervous system damage, that is, neuropathic pain. Central and peripheral nervous system changes have been extensively investigated in experimental animal models of neuropathic pain such as the chronic constriction or spared nerve injury models. These models produce sensory changes typically seen in people with neuropathic pain such as allodynia (pain produced by a non-noxious stimulus) and hyperalgesia (abnormally heightened sensitivity to pain) as well as alterations in social, feeding, sexual, and sleep-wake behaviors (Monassi and others 2003) . A limitation of much of the data exploring neuropathic pain in experimental animal models has been the overreliance on inferring a human-like ongoing pain state solely from measuring withdrawal reflexes. However, the advantages of using experimental animals includes the degree of control over the experimental paradigm as well as the possibility to explore the regional anatomy and alterations in function of individual neurons, astrocytes and microglia.
Primary Afferent Synapse
We know from experimental animal studies that neuropathic pain is associated with anatomical and functional changes in the dorsal horn/SpV. For example, nerve injury evokes neuronal degeneration, and loss of local inhibitory neurons in the region of the recipient primary synapse (Azkue and others 1998; de Novellis and others 2004; Scholz and others 2005; Sugimoto and others 1990; Whiteside and Munglani 2001) , which has been attributed to excessive, ongoing afferent excitation (Coggeshall and others 1993; Sloviter and Damiano 1981) . This neuronal loss may play an important role in the establishment of chronic pain, since a reduction of this neuronal loss by administration of inhibitors of caspase-dependent apoptosis reduces the occurrence of the sensory changes characteristic of neuropathic pain models in experimental animals (Scholz and others 2005; Whiteside and Munglani 2001) . In addition, there is a growing body of evidence of non-neural changes in the dorsal horn/SpV in animal models of chronic pain, particularly neuropathic pain. There are significant microglial changes as well as astrocyte activation in the dorsal horn/SpV following nerve injury and these changes are correlated to sensory changes such as allodynia and hyperalgesia (Gwak and others 2012; Scholz and Woolf 2007) . Furthermore, inhibition of neural activity or astrocyte activation reverses the mechanical allodynia induced nerve injury in experimental animals (Wang and others 2009 ). Though there is some evidence from postmortem studies that chronic neuropathic pain is associated with chronic astrocyte activation in the superficial dorsal horn (Shi and others 2012), it is not known whether these changes occur consistently in neuropathic pain conditions and whether such changes are responsible for altered brain activity and the ongoing perception of pain. To determine the underlying mechanisms responsible for chronic pain, it is critical that we verify in humans, changes reported in experimental animal models, particularly those in the dorsal horn/SpV and brainstem regions. Though few studies have explored the dorsal horn, some have explored the SpV in individuals with chronic pain, including those with neuropathic pain.
So is there evidence from brain imaging studies for anatomical and functional changes within the SpV of individuals with chronic orofacial pain?
The most common measures used to infer the presence of pain in experimental animal models are the presence of sensory changes such as hyperalgesia and allodynia. The importance of determining other indicators of the pain state have been highlighted recently; thus, in addition to sensory disturbances altered expression of complex behaviors such as social, feeding, and sleep-wake behaviors identify experimental animals most similar to human chronic pain populations (Keay and others 2004) . Nonetheless, there is some human brain evidence that altered sensitivity to acute noxious stimuli also occurs in individuals with chronic pain and that this increased sensitivity is associated with changes in the dorsal horn/SpV. Becerra and others (2006) found in individuals with unilateral trigeminal neuropathic pain that although noxious cold and heat evoked greater pain intensities when applied to the side of the face with on-going pain, they actually evoked reduced SpV activation when applied to that side of the face compared to when applied to the side of the face without ongoing pain.
In addition to altered evoked changes in dorsal horn/ SpV activity, the newly developed MRI technique arterial spin labelling allows for the measurement of resting blood flow as an index of ongoing activity. Although this technique typically requires scans with a lower spatial resolution than standard fMRI scans, it has begun to be used to explore resting blood flow in the brainstem of individuals with chronic pain. Youssef and others (2014) compared regional blood flow in individuals with chronic painful trigeminal neuropathy (PTN) with those with painful temporomandibular disorder (TMD). Similar to brain activation patterns during acute noxious stimuli, TMD, a condition thought to result primarily from nociceptive activation (Manfredini and Nardini 2010; Sarlani and Greenspan 2005) , was associated with increased ongoing blood flow within SpV as well as in higher brain regions such as the anterior cingulate and dorsolateral prefrontal cortices. Other non-neuropathic chronic pain conditions such as fibromyalgia (Wik and others 2003) and osteoarthritis (Kulkarni and others 2007) are also associated with blood flow increases in these higher brain regions in addition to increases in areas such as the somatosensory cortices.
In striking contrast, however, Youssef and others (2014) found that in individuals with PTN, a neuropathic pain condition resulting from nerve damage, there were no changes in SpV blood flow. Indeed, it appears that neuropathic pain is not associated with increased ongoing blood flow in brain regions that are activated by acute or chronic nociceptor activation. Instead, it appears that the most consistent resting blood flow change associated with neuropathic pain is an ongoing decrease in activity in the thalamus (Hsieh and others 1995; Iadarola and others 1995; Moisset and Bouhassira 2007; Youssef and others 2014) . Although it is possible that technical issues preclude the detection of very subtle changes in ongoing neural activity, these data strongly suggest that at least some forms of chronic pain are not associated with overt activity increases in the well-described ascending pain pathways, including the level at which nociceptor afferents terminate. Neuropathic pain is associated with altered thalamic firing patterns and altered thalamocortical rhythm (Sarnthein and others 2006; Walton and Llinás 2010) and it is possible that altered firing patterns and/or altered sensitivity to basal firing levels rather than overt increases in neural firing underlie the constant percept of pain. Since changes in the levels of inhibitory cell activity as well as changes in glial function can significantly alter the sensitivity and pattern of neural activity, it is important that we explore these aspects in humans with chronic pain. Although we cannot measure these aspects directly, a number of current brain imaging techniques allow for the investigation of regional neural structure and function.
For instance, using voxel-based morphometry of T1-weighted images, a technique that allows for the measurement of regional grey matter volume/density, and diffusion tensor imaging, a technique that measures the ease of free water movement, it was revealed that subjects with orofacial neuropathic pain have significantly reduced SpV grey matter volume and more restricted water movement, that is, reduced mean diffusivity (Wilcox and others 2015) . While the precise nature of the cellular changes underlying these SpV changes remain unclear, a decrease in grey matter volume may result from loss, shrinkage or atrophy of neurons or glia, or even synaptic loss (May and Gaser 2006) . Further, reduced mean diffusivity may result from tissue shrinkage and dense packing of myelinated fibers as a result of neurodegeneration and gliosis (Sierra and others 2011) . However, given experimental animal and human postmortem evidence of prolonged astrocyte activation in the dorsal horn/SpV associated with neuropathic pain, and given that activated astrocytes enlarge considerably, decreased SpV mean diffusivity likely results from chronic astrocyte activation. Although it is not possible to measure astrocyte activation in living humans, and no study has explored the anatomy of the spinal cord in individuals with chronic pain, these results suggest that, as happens in experimental animal models, neuropathic pain in humans in associated with chronic astrocyte activation at the level of the primary afferent synapse.
While we have presented evidence that neuropathic pain is not associated with a change in ongoing SpV blood flow, it is possible that SpV anatomical changes are associated with a change in resting rhythm. It is known that astrocytes can modulate synaptic function by the release of various gliotransmitters and that this release can occur in rhythmic waves at frequencies around 0.03 Hz. Furthermore, it has been proposed that in pathological situations, greater astrocyte activation may result in enhanced calcium wave synchrony and amplitude, and enhanced NMDA-receptor function (Halassa and others 2007; Parri and Crunelli 2001) . This astrocyte activation would result in increased infra-slow oscillatory power, which is coupled to high-frequency cortical power and paroxysmal events (Hughes and others 2011; Mantini and others 2007; Vanhatalo and others 2004) . It is possible that following nerve injury, astrocyte activation results in increased infra-slow oscillatory gliotransmitter release and increased resting oscillatory neural activity in the dorsal horn/SpV. Consistent with this idea, Alshelh and others (2015) found increased infra-slow oscillatory changes in SpV in individuals with neuropathic orofacial pain. Using fast Fourier transforms of resting state fMRI, they found increases in resting 0.03 to 0.06Hz power in the same SpV region in which there was a decrease in mean diffusivity and grey matter volume (Fig. 6 ).
Although in isolation these functional and anatomical findings cannot definitively establish underlying cellular changes, taken together they are consistent with the idea that following nerve injury, alterations in local neuronal populations in addition to changes in astrocyte function result in altered activity patterns, which may in turn evoke changes in local synaptic sensitivity, a change in brain rhythm and the constant perception of pain.
Higher Brainstem Regions
Although anatomical and functional changes in the dorsal horn/SpV are likely important for the development and/or maintenance of chronic pain, changes in other brainstem regions, especially those that can modulate activity in the dorsal horn/SpV, are also likely to be involved. The PAG and SRD, two brainstem regions that have the ability to significantly modulate incoming noxious inputs at the dorsal horn/SpV, have attracted attention for their potential role in the development and maintenance of chronic pain. This stems primarily from findings in humans that individuals with reduced endogenous analgesic ability are more likely to develop chronic pain and are less responsive to analgesic medications (Julien and others 2005; King and others 2009; Yarnitsky and others 2012) . More impressive are the results from experimental animal studies, which show that interrupting the PAG-RVM-dorsal horn/SpV circuitry prevents and reverses the sensory changes triggered in experimental neuropathic pain models. (Porreca and others 2001; Porreca and others 2002) .
Very few studies have focused specifically on activity within the PAG in individuals with chronic pain, and while some studies have explored changes in resting state connectivity between the PAG and higher brain regions (Truini and others 2016; Yu and others 2014) , no study has investigated activity in the descending PAG endogenous analgesic circuits in humans with chronic pain. However, there are some reports that chronic pain is associated with anatomical changes in the PAG and other brainstem regions. For example, in addition to reporting mean diffusivity decreases in the SpV in individuals with chronic orofacial neuropathic pain, Wilcox and others (2015) reported mean diffusivity decreases in the region of the PAG and the rostral ventromedial medulla. Furthermore, a recent meta-analysis of voxel-based morphometry changes in gray matter volume found that both neuropathic and non-neuropathic chronic The increase in infra-slow oscillation power was located in the same region in which there were significant decreases in grey matter volume (probability * volume) and mean diffusivity ([×10 −3 ] µm/ms). Combined, these findings are consistent with the idea that astrocyte activation is associated with increased infra-slow oscillatory activity in the ascending pain pathway. Location of each axial slice in Montreal Neurological Institute space is indicated at the top right. *P < 0.05. Modified from Alshelh and others (2015) and Wilcox and others (2015) .
pain states were associated with reduced volume in the region of the PAG (Cauda and others 2014) . These anatomical changes are again consistent with experimental animal studies, which show neural apoptosis and astrocyte activation in the PAG in experimental animal models of chronic pain (Mor and others 2010; Mor and others 2011) . Whether these anatomical changes underlie dysfunction in endogenous analgesic circuits or whether they underlie some of the behavioral changes associated with chronic pain is yet to be determined.
Conclusions
Despite the inherent difficulties in exploring the anatomy and function of the spinal cord and brainstem in living humans, it is important that we continue to explore these regions if we are to develop a greater understanding of the underlying mechanisms of many neurological conditions including chronic pain. While we have outlined some recent findings from investigations exploring the mechanisms of chronic pain in humans, much more work is to be done. The development of higher field MRI scanners in addition to advances in image analysis software will no doubt have a significant impact on the ease and quality of future brainstem and spinal cord imaging investigations. The marriage between experimental animal investigations and human imaging studies is critical since experimental animal work can reveal changes at a microscopic level that will likely never be available for exploration in living humans. However, if we can continue to explore neural changes in experimental animals and living humans we have a good chance of understanding the mechanisms underlying the development and maintenance of chronic pain in the not too distant future. Only when this is achieved will we be able to begin to develop targeting therapies that will be able to prevent and/or alleviate chronic pain in all individuals.
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